MedTrace Logo

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department

NCT01660867 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-01-09

No results posted yet for this study

Summary

This is a prospective, randomized, controlled, double-blinded, clinical trial

Subject : 3mo \~ 24mo. aged infants with bronchiolitis

The effect of 3 % NaCl nebulizer or dexamethasone on admission rate of these infants in ED.

Conditions

  • Acute Bronchiolitis

Interventions

DRUG

3% saline + oral placebo

nebulized epinephrine + 3% saline + placebo =\> nebulized epinephrine + 3% saline

DRUG

0.9% saline + oral dexamethasone

nebulized epinephrine + 0.9% saline + dexamethasone =\> nebulized epinephrine + 0.9% saline

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01660867 on ClinicalTrials.gov